ValueMax Group Limited Announces Allotment and Issuance of New Shares from Warrant Exercise

Key Highlights

• Increase in Issued Ordinary Shares: ValueMax Group Limited has issued 322,000 new ordinary shares following the exercise of 322,000 warrants at an exercise price of S\$0.36 each.
• Change in Share Capital: The company’s total issued ordinary shares has increased from 940,883,339 (excluding 100,000 treasury shares) to 941,205,339 ordinary shares.
• Listing Date for New Shares: The newly issued shares will be listed and quoted on the Singapore Exchange Securities Trading Limited (SGX-ST) on 2 February 2026.
• Outstanding Warrants: After this exercise, there are 6,599,970 outstanding warrants, each carrying the right to subscribe for one ordinary share at S\$0.36, expiring at 5:00 p.m. on 14 September 2026.

Details & Analysis for Shareholders

The recent exercise of warrants and subsequent allotment of new shares is an event of importance for shareholders and potential investors. This transaction results in a marginal increase in the company’s share capital, with the new shares ranking pari passu with existing shares. This means the new shares carry the same rights as existing shares, including voting and dividend entitlements.

Implications for Share Value

• Dilution Impact: The issuance of 322,000 new ordinary shares represents a very minor dilution (less than 0.04%) for existing shareholders. However, the potential for further dilution exists, as there remain 6,599,970 outstanding warrants that could be exercised before their expiry, which, if all exercised, would further increase the share capital.
• Capital Raised: The company has raised S\$115,920 (322,000 x S\$0.36) from this round of warrant exercise. If all outstanding warrants are exercised, the company stands to raise an additional S\$2,375,989.20.
• Shareholder Attention: Shareholders should monitor the pace and scale of future warrant exercises, as significant conversions could lead to further dilution or signal confidence from warrant holders about the company’s prospects.
• Price Sensitivity: The ongoing availability and exercise of warrants at S\$0.36 may provide a benchmark for share price expectations in the near term, especially as the expiry date approaches. Any significant uptick in warrant conversions could indicate bullish sentiment or signal a need for capital by the company.

Warrant Expiry Timeline

The outstanding warrants are set to expire on 14 September 2026, providing a window for potential further exercises. Investors should be aware of this timeline, as increased activity closer to expiry could impact share liquidity and price movements.

What Should Investors Watch?

• Monitor announcements of additional warrant exercises, as these may impact both dilution and capital inflow.
• Assess the company’s use of funds raised through warrant exercises, which could be directed towards growth initiatives or strengthening the balance sheet.
• Be alert for any corporate actions or strategic developments that may influence warrant holders’ decisions to exercise their rights.

Conclusion

The warrant exercise and subsequent share issuance may have a minor immediate impact on share dilution, but provides ValueMax Group Limited with additional capital. The presence of a significant number of outstanding warrants remains a factor for investors to consider, both for its potential dilution effect and as an indicator of future capital flows. Shareholders and market participants should continue to watch for further updates as the warrant expiry date approaches.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Readers should conduct their own research or consult a financial advisor before making any investment decisions. All information is based on public disclosures as of 29 January 2026.

View ValueMax W260914 Historical chart here